annual CFO:
-$108.56M-$64.68M(-147.41%)Summary
- As of today (July 26, 2025), ABCL annual cash flow from operations is -$108.56 million, with the most recent change of -$64.68 million (-147.41%) on December 31, 2024.
- During the last 3 years, ABCL annual CFO has fallen by -$353.14 million (-144.38%).
- ABCL annual CFO is now -139.14% below its all-time high of $277.36 million, reached on December 31, 2022.
Performance
ABCL Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$11.55M-$3.55M(-44.43%)Summary
- As of today (July 26, 2025), ABCL quarterly cash flow from operations is -$11.55 million, with the most recent change of -$3.55 million (-44.43%) on March 31, 2025.
- Over the past year, ABCL quarterly CFO has increased by +$30.15 million (+72.30%).
- ABCL quarterly CFO is now -104.23% below its all-time high of $273.01 million, reached on June 30, 2022.
Performance
ABCL quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$78.40M+$30.15M(+27.78%)Summary
- As of today (July 26, 2025), ABCL TTM cash flow from operations is -$78.40 million, with the most recent change of +$30.15 million (+27.78%) on March 31, 2025.
- Over the past year, ABCL TTM CFO has dropped by -$36.88 million (-88.82%).
- ABCL TTM CFO is now -122.36% below its all-time high of $350.59 million, reached on June 30, 2022.
Performance
ABCL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ABCL Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -147.4% | +72.3% | -88.8% |
| 3 y3 years | -144.4% | -111.5% | -133.3% |
| 5 y5 years | -4129.6% | -1412.3% | -411.0% |
ABCL Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -139.1% | at low | -104.2% | +90.9% | -122.4% | +34.8% |
| 5 y | 5-year | -139.1% | at low | -104.2% | +90.9% | -122.4% | +34.8% |
| alltime | all time | -139.1% | at low | -104.2% | +90.9% | -122.4% | +34.8% |
ABCL Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$11.55M(+44.4%) | -$78.40M(-27.8%) |
| Dec 2024 | -$108.56M(+147.4%) | -$8.00M(-72.3%) | -$108.56M(-9.7%) |
| Sep 2024 | - | -$28.88M(-3.6%) | -$120.17M(+31.5%) |
| Jun 2024 | - | -$29.97M(-28.2%) | -$91.39M(+120.1%) |
| Mar 2024 | - | -$41.71M(+112.7%) | -$41.52M(-5.4%) |
| Dec 2023 | -$43.88M(-115.8%) | -$19.61M(>+9900.0%) | -$43.88M(-760.2%) |
| Sep 2023 | - | -$106.00K(-100.5%) | $6.65M(-105.5%) |
| Jun 2023 | - | $19.90M(-145.2%) | -$120.03M(-190.2%) |
| Mar 2023 | - | -$44.06M(-242.5%) | $133.08M(-52.0%) |
| Dec 2022 | $277.36M | $30.91M(-124.4%) | $277.36M(+20.7%) |
| Sep 2022 | - | -$126.79M(-146.4%) | $229.74M(-34.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $273.01M(+172.4%) | $350.59M(+49.0%) |
| Mar 2022 | - | $100.22M(-699.7%) | $235.26M(-3.8%) |
| Dec 2021 | $244.58M(+977.9%) | -$16.71M(+181.7%) | $244.58M(-6.9%) |
| Sep 2021 | - | -$5.93M(-103.8%) | $262.57M(-0.8%) |
| Jun 2021 | - | $157.68M(+43.9%) | $264.70M(+99.0%) |
| Mar 2021 | - | $109.55M(+8471.6%) | $133.00M(+486.2%) |
| Dec 2020 | $22.69M(+742.2%) | $1.28M(-133.6%) | $22.69M(+6.0%) |
| Sep 2020 | - | -$3.80M(-114.6%) | $21.41M(-15.1%) |
| Jun 2020 | - | $25.98M(-3500.1%) | $25.21M(-3400.1%) |
| Mar 2020 | - | -$764.00K | -$764.00K |
| Dec 2019 | $2.69M(-24.4%) | - | - |
| Dec 2018 | $3.56M | - | - |
FAQ
- What is AbCellera Biologics Inc. annual cash flow from operations?
- What is the all time high annual CFO for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual CFO year-on-year change?
- What is AbCellera Biologics Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly CFO year-on-year change?
- What is AbCellera Biologics Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. TTM CFO year-on-year change?
What is AbCellera Biologics Inc. annual cash flow from operations?
The current annual CFO of ABCL is -$108.56M
What is the all time high annual CFO for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual cash flow from operations is $277.36M
What is AbCellera Biologics Inc. annual CFO year-on-year change?
Over the past year, ABCL annual cash flow from operations has changed by -$64.68M (-147.41%)
What is AbCellera Biologics Inc. quarterly cash flow from operations?
The current quarterly CFO of ABCL is -$11.55M
What is the all time high quarterly CFO for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly cash flow from operations is $273.01M
What is AbCellera Biologics Inc. quarterly CFO year-on-year change?
Over the past year, ABCL quarterly cash flow from operations has changed by +$30.15M (+72.30%)
What is AbCellera Biologics Inc. TTM cash flow from operations?
The current TTM CFO of ABCL is -$78.40M
What is the all time high TTM CFO for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high TTM cash flow from operations is $350.59M
What is AbCellera Biologics Inc. TTM CFO year-on-year change?
Over the past year, ABCL TTM cash flow from operations has changed by -$36.88M (-88.82%)